Banyan Bio

Venture Capital Exempt reporting adviser

Legal name: Banyan Bioinnovations Capital Fund I LP

Boston, MA Website LinkedIn

AUM

$100.0M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$100.0M
Gross asset value

Employees

—

Last Form D raise

Jun 2026
Most recent fund filing

From SEC Form ADV filing (filed Sep 9, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

A
Andrew Meyerson
Managing Director
Source: SEC Form ADV
D
Daniel Brog
Managing Director
Source: SEC Form ADV
G
Geoffrey Meyerson
Chief Executive Officer
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Banyan Bioinnovations Capital Fund I LPVenture Capital$100.0M$102.0M1Jun 2026Hot

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
342873
SEC file number
802-137481

Sources